Literature DB >> 6268140

Penicillanic acid sulfone: an unexpected isotope effect in the interaction of 6 alpha- and 6 beta-monodeuterio and of 6,6-dideuterio derivatives with RTEM beta-lactamase from Escherichia coli.

D G Brenner, J R Knowles.   

Abstract

Penicillanic acid sulfone (1) is both a substrate and an inactivator of the RTEM beta-lactamase. About 7000 hydrolytic events occur before enzyme inactivation. The 6,6-dideuterio sulfone shows a 3-fold acceleration of both the hydrolysis reaction and the enzyme inactivation. The kinetic and spectroscopic results are nicely accommodated by a scheme in which a transiently stable intermediate is formed in an isotopically sensitive step. The deuterated material partitions less readily toward this transiently stable intermediate by virtue of a primary isotope effect, and more enzyme is then available for the hydrolysis and inactivation pathways. Use of the stereospecifically monodeuterated sulfones shows that the 6 beta hydrogen is preferentially abstracted in the formation of the transiently stable intermediate and allows a detailed picture of the interaction of the sulfone and the beta-lactamase to be drawn. The crystal structures of both the labeled and unlabeled compounds are reported.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6268140     DOI: 10.1021/bi00516a003

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  27 in total

1.  Reaction of cis-3-chloroacrylic acid dehalogenase with an allene substrate, 2,3-butadienoate: hydration via an enamine.

Authors:  Gottfried K Schroeder; William H Johnson; Jamison P Huddleston; Hector Serrano; Kenneth A Johnson; Christian P Whitman
Journal:  J Am Chem Soc       Date:  2011-12-19       Impact factor: 15.419

2.  Inhibition of class C beta-lactamases by (1'R,6R)-6-(1'-hydroxy)benzylpenicillanic acid SS-dioxide.

Authors:  G C Knight; S G Waley
Journal:  Biochem J       Date:  1985-01-15       Impact factor: 3.857

3.  Rational design of a beta-lactamase inhibitor achieved via stabilization of the trans-enamine intermediate: 1.28 A crystal structure of wt SHV-1 complex with a penam sulfone.

Authors:  Pius S Padayatti; Anjaneyulu Sheri; Monica A Totir; Marion S Helfand; Marianne P Carey; Vernon E Anderson; Paul R Carey; Christopher R Bethel; Robert A Bonomo; John D Buynak; Focco van den Akker
Journal:  J Am Chem Soc       Date:  2006-10-11       Impact factor: 15.419

Review 4.  Beta-lactamase inhibitors from laboratory to clinic.

Authors:  K Bush
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

5.  Kinetic interactions of tazobactam with beta-lactamases from all major structural classes.

Authors:  K Bush; C Macalintal; B A Rasmussen; V J Lee; Y Yang
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

6.  Correlation of the effect of beta-lactamase inhibitors on the beta-lactamase in growing cultures of gram-negative bacteria with their effect on the isolated beta-lactamase.

Authors:  C J Easton; J R Knowles
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

7.  Kinetic studies on inactivation of Citrobacter freundii cephalosporinase by sulbactam.

Authors:  A Yamaguchi; T Hirata; T Sawai
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

8.  Novel carbapenem derivative SF2103A: studies on the mode of beta-lactamase inactivation.

Authors:  A Yamaguchi; T Hirata; T Sawai
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

9.  Activities and sources of beta-lactamase in sputum from patients with bronchiectasis.

Authors:  P Dragicevic; S L Hill; D Burnett; D Merrikin; R A Stockley
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

10.  Kinetic characterization of hydrolysis of nitrocefin, cefoxitin, and meropenem by β-lactamase from Mycobacterium tuberculosis.

Authors:  Carmen Chow; Hua Xu; John S Blanchard
Journal:  Biochemistry       Date:  2013-05-30       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.